Enfortumab vedotin: as the comparator
4 studies: what is tested is compared with it. Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUCRecruitingNCT07720284Phase 3Report a problem
- Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)Not yet recruitingNCT07662863Phase 2Report a problem
- SYS6002 vs PADCEV in Patients With Advanced Urothelial CarcinomaNot yet recruitingNCT07374549Phase 2Report a problem
- Modular Trial of sEphB4-HSA in EphrinB2-High Solid TumorsRecruitingNCT06493552Phase 2/3Report a problem